Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lipoprotein(a). Link between structure and pathology.

A M Scanu1

  • 1Department of Medicine, University of Chicago, IL 60637.

Annals of Epidemiology
|July 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lipoprotein(a) as a cardiovascular risk factor.

Trends in cardiovascular medicine·2011
Same author

Apolipoprotein A-II and Serum High-Density Lipoproteins: A Model System for the Study of Protein-Lipid Interactions at a Natural Hydrophilic-Hydrophobic Interface.

Biophysical journal·2009
Same author

[Primary aortoenteric fistula. Report of a case].

Annali italiani di chirurgia·2004
Same author

Three cases of cardiac hydatidosis: diagnosis, surgical treatment, and complications.

International surgery·2002
Same author

99mTc-Tetrofosmin pinhole-SPECT (P-SPECT) and radioguided sentinel node (SN) biopsy and in breast cancer axillary lymph node staging.

Cancer biotherapy & radiopharmaceuticals·2002
Same author

(99)mTc-tetrofosmin SPET in the detection of both primary breast cancer and axillary lymph node metastasis.

European journal of nuclear medicine·2001
Same journal

Retention Strategies and Participant Retention Rates Among Prospective Longitudinal Pregnancy Cohorts: A Systematic Mapping Review.

Annals of epidemiology·2026
Same journal

Contribution of lifestyle factors to sex differences in educational inequalities in life expectancy in selected European countries.

Annals of epidemiology·2026
Same journal

What remains quantitative in quantitative intersectionality?

Annals of epidemiology·2026
Same journal

Revisiting the role of interaction effects in quantitative intersectionality research.

Annals of epidemiology·2026
Same journal

GLP-1 receptor agonist medications for weight loss: Sociodemographic patterns of awareness, use, and access in a U.S. national cohort.

Annals of epidemiology·2026
Same journal

Even low levels of physical activity are associated with lower all-cause mortality: A cohort study of 594,000 US adults.

Annals of epidemiology·2026
See all related articles

High levels of lipoprotein(a) increase cardiovascular risk. Mechanisms involve lipoprotein(a) entering arteries, interacting with fibrinogen, and potentially forming foam cells, contributing to atherosclerosis.

Area of Science:

  • Cardiovascular Science
  • Lipid Metabolism
  • Atherosclerosis Research

Background:

  • High plasma lipoprotein(a) levels are linked to increased atherosclerotic cardiovascular disease risk.
  • The precise mechanisms driving this association remain unclear.
  • Lipoprotein(a) is an LDL-like particle with apolipoprotein B100 and apolipoprotein(a), and can be triglyceride-rich.

Purpose of the Study:

  • To elucidate the mechanisms by which lipoprotein(a) contributes to atherosclerotic cardiovascular disease.
  • To investigate the structural characteristics and arterial wall interactions of lipoprotein(a).

Main Methods:

  • Review of existing studies on lipoprotein(a) structure and function.
  • Analysis of immunochemical evidence regarding apolipoprotein(a) localization in the artery wall.

Related Experiment Videos

  • Exploration of potential atherogenic pathways involving lipoprotein(a).

    • Main Results:

    • Lipoprotein(a) can penetrate the endothelium and accumulate in the arterial intima.
    • Apolipoprotein(a) in the artery wall co-localizes with fibrin(ogen), suggesting a role in atherogenesis.
    • Chemical modification of lipoprotein(a) by oxidative stress or matrix interactions may promote foam cell formation.

    Conclusions:

    • Lipoprotein(a) accumulation in the arterial wall, potentially via interaction with fibrinogen and chemical modification, is a key mechanism in atherosclerosis.
    • Lipoprotein(a) may be a significant source of apolipoprotein B in atherosclerotic lesions.
    • The influence of apolipoprotein(a) size, lipoprotein(a) density, and apolipoprotein(a) polymorphism on arterial accumulation requires further investigation.